Skip to Main Content

Paper Details

Novel renal medullary carcinoma cell lines, UOK353 and UOK360, provide preclinical tools to identify new therapeutic treatments.
Genes Chromosomes Cancer
6
2020
EZH2, N-acetyl cysteine, Patients, RMC, RMC tumor spheroids, RMCs, Renal medullary carcinoma, SMARCB1, SMARCB1 tumor suppressor protein, UOK353, UOK360, bortezomib, cell line models, cell lines, cisplatin, patients, polycomb repressive complex, primary RMCs, renal cell carcinoma, renal medullary carcinoma, renal medullary carcinoma cell lines, sickle cell trait, tumors
Author NameAffiliation
Christopher J RickettsCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Darawalee WangsaCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Darawalee WangsaCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Danny WangsaCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Danny WangsaCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Rajarshi GuhaDivision of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health
Rajarshi GuhaDivision of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health
Xiaohu ZhangDivision of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health
Paul S MeltzerCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Paul S MeltzerCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Thomas RiedCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Thomas RiedCenter for Cancer Research, National Cancer Institute, National Institutes of Health
Craig J ThomasDivision of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health
Maria J MerinoNational Cancer Institute, National Institutes of Health
Maria J MerinoNational Cancer Institute, National Institutes of Health
William Marston LinehanCenter for Cancer Research, National Cancer Institute, National Institutes of Health
  • 1 - 16

Datasets